Selected ImmuHub® Publications

Applications of immune repertoire sequencing across cancer immunology, infectious disease, vaccines, autoimmunity and antibody research.

Platform evidence

A growing body of peer-reviewed research

ImmuQuad’s official publication page currently reports 63 SCI papers and a cumulative impact factor of 857.0. The selection below highlights recent and representative repertoire studies.

Metrics are a snapshot of the official publication page accessed in July 2026 and may change as new work is published.

67SCI publications listed
903.6Cumulative impact factor reported
2026

Perp Deficiency Induces Defective Negative Selection and Autoimmune Arthritis in Aged Mice

Aging Cell · T-cell selection and autoimmunity
View article ↗
2026

Cold Atmospheric Plasma–Engineered Nanovaccine with Spatiotemporal Sequential Immunization Reprograms Antitumor Immunity

Science Advances · Cancer vaccine and T-cell repertoire
View article ↗
2025

Enhancement of Immune Checkpoint Inhibitor Efficacy by DHX58+ SELL+ T Cells in Advanced Gastric Cancer

Visualized Cancer Medicine · Immunotherapy response
View article ↗
2024

T-cell Receptor and B-cell Receptor Repertoires Profiling in Pleural Tuberculosis

Frontiers in Immunology · TRB, TRG and IGH profiling
View article ↗
2022

Predictive Value of Next-generation Sequencing-based Minimal Residual Disease after CAR-T Cell Therapy

Bone Marrow Transplantation · NGS-MRD and CAR-T
View article ↗
2022

The Relationship Between Convergent IGH Signatures and Severity of COVID-19 Patients

Frontiers in Microbiology · BCR repertoire and infection
View article ↗